TLCM
EDIT icon

Twin Lakes Capital Management’s Editas Medicine EDIT Stock Holding History

Twin Lakes Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05K Hold
1,250
– – ﹤0.01% 187
2026
Q1 		$3.09K Hold
1,250
– – ﹤0.01% 202
2025
Q4 		$2.56K Hold
1,250
– – ﹤0.01% 211
2025
Q3 		$4.34K Hold
1,250
– – ﹤0.01% 205
2025
Q2 		$2.75K Hold
1,250
– – ﹤0.01% 209
2025
Q1 		$1.45K Hold
1,250
– – ﹤0.01% 216
2024
Q4 		$1.59K Hold
1,250
– – ﹤0.01% 229
2024
Q3 		$4.26K Hold
1,250
– – ﹤0.01% 218
2024
Q2 		$5.84K Hold
1,250
– – ﹤0.01% 219
2024
Q1 		$9.28K Hold
1,250
– – 0.01% 208
2023
Q4 		$12.7K Hold
1,250
– – 0.01% 194
2023
Q3 		$9.75K Hold
1,250
– – 0.01% 209
2023
Q2 		$10.3K Hold
1,250
– – 0.01% 204
2023
Q1 		$9.06K Hold
1,250
– – 0.01% 207
2022
Q4 		$11.1K Hold
1,250
– – 0.01% 202
2022
Q3 		$15K Buy
+1,250
New +$19.5K 0.01% 192
2022
Q2 		– Sell
-1,250
Closed -$24K – 184
2022
Q1 		$24K Buy
+1,250
New +$23.2K 0.01% 188

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Twin Lakes Capital Management's EDIT Position: Q2 2026 in Review

Twin Lakes Capital Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 1,250 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #187.

Twin Lakes Capital Management first reported a position in EDIT in Q1 2022 and has held it in 17 quarters since. The position peaked at $24K in Q1 2022. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Twin Lakes Capital Management held 1,250 shares of Editas Medicine worth $4.05K as of Q2 2026.
  • Twin Lakes Capital Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Twin Lakes Capital Management's portfolio in Q2 2026, its #187 holding.
  • Twin Lakes Capital Management first reported a position in Editas Medicine in Q1 2022 and has held it in 17 quarters since.
  • Twin Lakes Capital Management's Editas Medicine position peaked at $24K in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.